For those with IBS-D (diarrhoea-predominant IBS), there can be some improvements in bowel urgency and/or frequency
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA , 2021))
As a result, these incretin hormones remain active for a longer period, allowing them to more effectively: Stimulate insulin secretion, Suppress glucagon secretion, and Ultimately, lower blood glucose levels
When timed right, they create a beautiful biochemical symphony
Randomization was conducted using an interactive web response system, assigning participants in a 6:1 ratio to one of several treatment arms: once-weekly subcutaneous Cagrilintide administered in doses of 0.3, 0.6, 1.2, 2.4, or 4.5 mg, once-daily liraglutide 3.0 mg, or a volume-matched placebo
In many countries, being overweight or obese has become as concerning as malnutrition under-fives